Skip to main content

Primary Autoimmune Warm Antibody Hemolytic Anemias

  • Chapter
  • First Online:
Nonmalignant Hematology

Abstract

A 40-year-old woman is referred to you for a diagnostic evaluation of anemia. Until recently, she was asymptomatic and in good health. She has two healthy children aged 8 and 10 years. For a few weeks, she has been feeling weak for unknown reasons. In a laboratory examination of her blood, she had anemia with a hemoglobin of 9.0 g/dl with a normal leukocyte and platelet count.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Allgood JW, Chaplin Jr H. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med. 1967;43(2):254–73.

    Article  CAS  PubMed  Google Scholar 

  • Arthold C, Skrabs C, Mitterbauer-Hohendanner G, et al. Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings. Wien Klin Wochenschr. 2014;126(11–12):376–82.

    Article  CAS  PubMed  Google Scholar 

  • Barcellini W, Zaja F, Zaninoni A, et al. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia. Eur J Haematol. 2013;91(6):546–51.

    Article  CAS  PubMed  Google Scholar 

  • Berentsen S, Ulvestad E, Gjertsen BT, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood. 2004;103(8):2925–8.

    Article  CAS  PubMed  Google Scholar 

  • Berentsen S, Ulvestad E, Langholm R, et al. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica. 2006;91(4):460–6.

    PubMed  Google Scholar 

  • Birgens H, Frederiksen H, Hasselbalch HC, et al. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol. 2013;163(3):393–9.

    Article  CAS  PubMed  Google Scholar 

  • Bolze A, Mahlaoui N, Byun M, et al. Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia. Science. 2013;340(6135):976–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coon WW. Splenectomy in the treatment of hemolytic anemia. Arch Surg. 1985;120(5):625–8.

    Article  CAS  PubMed  Google Scholar 

  • D’Arena G, Laurenti L, Capalbo S, et al. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Am J Hematol. 2006;81(8):598–602.

    Article  PubMed  Google Scholar 

  • D’Arena G, Califano C, Annunziata M, et al. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. Eur J Haematol. 2007;79(1):53–8.

    Article  PubMed  Google Scholar 

  • Gilbert B, Menetrey C, Belin V, et al. Familial isolated congenital asplenia: a rare, frequently hereditary dominant condition, often detected too late as a cause of overwhelming pneumococcal sepsis. Report of a new case and review of 31 others. Eur J Pediatr. 2002;161(7):368–72.

    Article  PubMed  Google Scholar 

  • Hauswirth AW, Skrabs C, Schützinger C, et al. Autoimmune hemolytic anemias, Evans’ syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma. 2007;48(6):1139–49.

    Article  PubMed  Google Scholar 

  • Hill J, Walsh RM, McHam S, et al. Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature. Am J Hematol. 2004;75(3):134–8.

    Article  PubMed  Google Scholar 

  • Hirokawa M, Sawada K, Fujishima N, et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol. 2009;84(3):144–8.

    Article  PubMed  Google Scholar 

  • Kaufman M, Limaye SA, Driscoll N, et al. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia. Leuk Lymphoma. 2009;50(6):892–9.

    Article  CAS  PubMed  Google Scholar 

  • Kulpa J, Skrabs C, Simanek R et al. Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia. Wien Klin Wochenschr. 2016;128(7-8):234–7.

    Google Scholar 

  • Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010;116(11):1831–8.

    Article  CAS  PubMed  Google Scholar 

  • Macdougall IC, Roger SD, de Francisco A, et al. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int. 2012;81(8):727–32.

    Article  CAS  PubMed  Google Scholar 

  • Mahlaoui N, Minard-Colin V, Picard C, et al. Isolated congenital asplenia: a French nationwide retrospective survey of 20 cases. J Pediatr. 2011;158(1):142–8. 148.e1.

    Article  PubMed  Google Scholar 

  • Maung SW, Leahy M, O’Leary HM, et al. A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia. Br J Haematol. 2013;163(1):118–22.

    Article  CAS  PubMed  Google Scholar 

  • Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood. 2000;95(9):2786–92.

    CAS  PubMed  Google Scholar 

  • Murphy S, LoBuglio AF. Drug therapy of autoimmune hemolytic anemia. Semin Hematol. 1976;13(4):323–34.

    CAS  PubMed  Google Scholar 

  • Nazi I, Kelton JG, Larché M, et al. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 2013;122(11):1946–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Payne D, Muss HB, Homesley HD, et al. Autoimmune hemolytic anemia and ovarian dermoid cysts: case report and review of the literature. Cancer. 1981;48(3):721–4.

    Article  CAS  PubMed  Google Scholar 

  • Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev. 2008;22(1):1–15.

    Article  PubMed  Google Scholar 

  • Puthenparambil J, Lechner K, Kornek G. Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors. A critical analysis of 52 cases reported in literature. Wien Klin Wochenschr. 2010;122:229–36.

    Article  CAS  PubMed  Google Scholar 

  • Quinquenel A, Willekens C, Dupuis J, et al. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS). Am J Hematol. 2015;90(3):204–7.

    Google Scholar 

  • Reynaud Q, Durieu I, Dutertre M, et al. Efficacy and safety of rituximab in auto-immune hemolytic anemia: a meta-analysis of 21 studies. Autoimmun Rev. 2015;14(4):304–13. pii: S1568-9972(14)00286-9.

    Google Scholar 

  • Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol. 2008;142(4):505–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sokol RJ, Booker DJ, Stamps R. Erythropoiesis: paroxysmal cold haemoglobinuria: a clinico-pathological study of patients with a positive donath-landsteiner test. Hematology. 1999;4(2):137–64.

    Article  PubMed  Google Scholar 

  • Thomsen RW, Schoonen WM, Farkas DK, et al. Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study. J Thromb Haemost. 2010;8:1413–6. Epub ahead of print.

    Article  CAS  PubMed  Google Scholar 

  • Yamamura K, Joo K, Ohga S, et al. Thrombocytosis in asplenia syndrome with congenital heart disease: a previously unrecognized risk factor for thromboembolism. Int J Cardiol. 2013;167(5):2259–63.

    Article  PubMed  Google Scholar 

  • Zent CS, Ding W, Reinalda MS, et al. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. Leuk Lymphoma. 2009;50(8):1261–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • ZupaÅ„ska B, Sylwestrowicz T, Pawelski S. The results of prolonged treatment of autoimmune haemolytic anaemia. Haematologia (Budap). 1981;14(4):425–33.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Krauth, M.T., Lechner, K. (2016). Primary Autoimmune Warm Antibody Hemolytic Anemias. In: Abutalib, S., Connors, J., Ragni, M. (eds) Nonmalignant Hematology. Springer, Cham. https://doi.org/10.1007/978-3-319-30352-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30352-9_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30350-5

  • Online ISBN: 978-3-319-30352-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics